Nanoparticles in Biotechnology, Drug Development and Drug Delivery Market Forecast 2012 - 2018


Posted November 11, 2016 by john55364

Use of nanoparticles in pharmaceutical technology is mainly driven by growth in demand for personalized medicine

 
Nanoscience or nanotechnology is the study of management of materials at molecular or atomic scale on different applications. The market for nanoparticles in drug technology holds prime share in the global pharmaceuticals market. Applications of nanotechnology can be classified into nanomedicine, chemicals and cosmetics, materials, food technology, energy, military, electronics, agriculture and others.

Download the -Industry Fact Sheet by 2018
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=877

Use of nanoparticles in pharmaceutical technology is mainly driven by growth in demand for personalized medicine. This market is classified according to applications such as biotechnology, drug development, and drug delivery. The biotechnology market is further classified according to the use of nanoparticles in fields such as research and development, cellular repair, stem cell research, in vitro imaging, biosensors among many others. The major areas in drug development and drug formulation where nanoparticles are substantially used are bioseparation, drug analysis, analysis and removal of toxins, incorporation of insoluble drugs, DNA nanoparticle development, screening of drug candidates and others.

This market is at present experiencing large scale patent acquisition, collaborations and mergers. The U.S. is viewed as the largest market for use of nanoparticles in pharma technology. The major geographical markets for nanoparticles in this technology are North America, Asia Pacific, Europe and Rest of the World.

View exclusive Global strategic Business report:
http://www.transparencymarketresearch.com/nanoparticles-in-biotechnology.html

Some of the market players in this industry are Astrazeneca Pharmaceuticals, PLC, Abraxis Biosciences, Inc., Novartis International AG, GE Global Research, Nano Interface Technology, Inc., Amag Pharmaceuticals Inc. and some others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends.

Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Transparency Market Research
Country United States
Categories Health , Industry
Tags drug development and drug delivery market , nanoparticles in biotechnology market , nanoparticles in biotechnology , drug development and drug delivery market
Last Updated November 11, 2016